Late Clinical and Laboratory Manifestations of Thorotrast Administration in Cerebral Arteriography
- 25 July 1968
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 279 (4) , 186-189
- https://doi.org/10.1056/nejm196807252790404
Abstract
Thirty patients who received thorotrast for cerebral arteriography from 1948 to 1952 were studied to determine the delayed effects of chronic low-dose internal-emitter radiation. The whole-body burdens ranged from 0.13 to 2.5 gram-equivalents of radioactive thorium and varied with the total amount of thorotrast originally administered. Bromsulfalein retention ranged from 5 to 27 per cent, and alkaline phosphatase from 4.7 to 9.8 units in over half the patients. Most had a moderate relative increase in the albumin and a decrease in the globulin fraction on serum protein electrophoresis. Only three patients had completely normal results on liver-function tests. Chromosome analyses of white blood cells revealed chromosomal breaks and abnormalities in nine of 10 patients.Keywords
This publication has 12 references indexed in Scilit:
- Late changes in peripheral blood after thorotrast administration.BMJ, 1967
- A Follow-up Study of a Group of Patients who Received Thorium Dioxide for Cerebral ArteriographyRadiology, 1967
- Cytogenetic Changes Following Thorotrast AdministrationInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1967
- Body Content of Thorium 232 Daughters after Thorotrast InjectionThe British Journal of Radiology, 1965
- MALIGNANCY AND OTHER LATE EFFECTS FOLLOWING ADMINISTRATION OF THOROTRASTThe Lancet, 1965
- Treatment of Thorium Dioxide Granulomas of the NeckNew England Journal of Medicine, 1963
- THOROTRAST TUMOURSActa Pathologica Microbiologica Scandinavica, 1961
- Chromosome preparations of leukocytes cultured from human peripheral bloodExperimental Cell Research, 1960
- THE LATE EFFECTS OF INTERNALLY-DEPOSITED RADIOACTIVE MATERIALS IN MANMedicine, 1952